These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 22509701)

  • 1. [Patient with recurrent central serous chorioretinopathy who developed multiple evanescent white dots and serous retinal detachment immediately following bevacizumab administration].
    Satoh S; Miyagawa Y; Mori T
    Nippon Ganka Gakkai Zasshi; 2012 Feb; 116(2):119-28. PubMed ID: 22509701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report.
    Liu Y; Wang X; Zhu M; Xu G; Li L
    BMC Ophthalmol; 2019 Mar; 19(1):68. PubMed ID: 30849939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization.
    Hage R; Mrejen S; Krivosic V; Quentel G; Tadayoni R; Gaudric A
    Am J Ophthalmol; 2015 May; 159(5):890-903.e3. PubMed ID: 25709063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroidal neovascularization in a patient with blunt trauma-caused traumatic retinopathy without choroidal rupture.
    Takahashi M; Kinoshita S; Saito W; Kase M; Ishida S
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):137-40. PubMed ID: 20714747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy.
    Montero JA; Ruiz-Moreno JM; Fernandez-Muñoz M
    Eur J Ophthalmol; 2011; 21(4):503-5. PubMed ID: 21279982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy].
    Cornut PL; Quaranta-El Maftouhi M; Mauget-Faÿsse M
    J Fr Ophtalmol; 2012 Feb; 35(2):82-7. PubMed ID: 21889817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy.
    Pikkel J; Rumelt S
    Eur J Ophthalmol; 2012; 22(3):488-91. PubMed ID: 21928270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of macular diseases--morphology and function].
    Iida T
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
    Song IS; Shin YU; Lee BR
    Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
    Chan WM; Lai TY; Liu DT; Lam DS
    Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serous retinal detachment following combined photodynamic therapy and intravitreal bevacizumab injection.
    Kim EY; Kim JW; Kim JB; Lew HM
    Korean J Ophthalmol; 2009 Jun; 23(2):124-6. PubMed ID: 19568365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab for iatrogenic choroidal neovascularization due to laser photocoagulation in central serous chorioretinopathy.
    Nomura Y; Obata R; Yanagi Y
    Jpn J Ophthalmol; 2012 May; 56(3):245-9. PubMed ID: 22526618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and sustained resolution of serous retinal detachment in Sturge-Weber syndrome after single injection of intravitreal bevacizumab.
    Shoeibi N; Ahmadieh H; Abrishami M; Poorzand H
    Ocul Immunol Inflamm; 2011 Oct; 19(5):358-60. PubMed ID: 21823932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Photodynamic Therapy Treatment of Central Serous Chorioretinopathy.
    Putnam CM; Vang SS
    Optom Vis Sci; 2016 Jul; 93(7):760-71. PubMed ID: 27058592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
    Zhang Z; Bao X; Wu Z; Zhang J
    Medicine (Baltimore); 2021 Feb; 100(7):e24790. PubMed ID: 33607835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of one-year follow-up examinations after intravitreal bevacizumab administration for chronic central serous chorioretinopathy.
    Inoue M; Kadonosono K; Watanabe Y; Kobayashi S; Yamane S; Arakawa A
    Ophthalmologica; 2011; 225(1):37-40. PubMed ID: 20693820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.